Insys Must Divest Subsys, Buprenorphine Candidate Products As Part Of Corporate Integrity Agreement
Settlement with US government also includes $225m payment to resolve criminal and civil cases related to illegal marketing of the sublingual fentanyl spray Subsys.
You may also be interested in...
Purdue's rise and fall through opioids will likely end in bankruptcy, raising new questions around ongoing lawsuits and shining a light on the toll the opioid liability will leave on the industry.
The latest drug development news and highlights from our US FDA Performance Tracker.
In opening statements, Oklahoma suggests award could be 'just shy of $13bn' if it takes 20 years to fix the problem.